Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004026905 | SCV000851077 | uncertain significance | not specified | 2016-06-07 | criteria provided, single submitter | clinical testing | The p.N596D variant (also known as c.1786A>G), located in coding exon 2 of the KIAA2022 gene, results from an A to G substitution at nucleotide position 1786. The asparagine at codon 596 is replaced by aspartic acid, an amino acid with highly similar properties. This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6503 samples with coverage at this position. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV001862075 | SCV002299573 | benign | not provided | 2022-11-01 | criteria provided, single submitter | clinical testing |